Taysha Gene Therapies Inc (TSHA): Next-Year EPS Estimate 32.60%
As of 2026-06-04, Taysha Gene Therapies Inc (TSHA) has a next-year EPS growth estimate of 32.60%.
On 2026-05-10, analyst consensus for TSHA's next-year EPS growth shifted from 33.95% to 32.60% — a negative change of 1.35 percentage points. The revised estimate has been sustained across 20 subsequent trading sessions. Current-year growth is projected at -39.82%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 32.60%
- EPS growth this year
- -39.82%
- EPS next quarter (est)
- -$0.12
- Last price
- $5.89
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 32.60% | -39.82% | -$0.12 | $5.89 |
| 2026-06-03 | 32.60% | -39.82% | -$0.12 | $5.55 |
| 2026-06-02 | 32.60% | -39.82% | -$0.12 | $5.69 |
| 2026-06-01 | 32.60% | -39.82% | -$0.12 | $5.97 |
| 2026-05-31 | 32.60% | -39.82% | -$0.12 | $5.87 |
| 2026-05-28 | 32.60% | -39.82% | -$0.12 | $5.92 |
| 2026-05-27 | 32.60% | -39.82% | -$0.12 | $5.75 |
| 2026-05-26 | 32.60% | -39.82% | -$0.12 | $5.59 |
| 2026-05-25 | 32.60% | -39.82% | -$0.12 | $5.49 |
| 2026-05-24 | 32.60% | -39.82% | -$0.12 | $5.49 |
| 2026-05-21 | 32.60% | -39.82% | -$0.12 | $5.54 |
| 2026-05-20 | 32.60% | -39.82% | -$0.12 | $5.49 |
| 2026-05-19 | 32.60% | -39.82% | -$0.12 | $5.18 |
| 2026-05-18 | 32.60% | -39.82% | -$0.12 | $5.45 |
| 2026-05-17 | 32.60% | -39.82% | -$0.12 | $5.96 |
| 2026-05-14 | 32.60% | -39.82% | -$0.12 | $6.30 |
| 2026-05-13 | 32.60% | -39.82% | -$0.12 | $6.59 |
| 2026-05-12 | 32.60% | -39.82% | -$0.12 | $6.85 |
| 2026-05-11 | 32.60% | -39.82% | -$0.12 | $6.82 |
| 2026-05-10 | 32.60% | -39.82% | -$0.12 | $6.81 |
| 2026-05-07 | 33.95% | -37.10% | -$0.12 | $6.67 |
| 2026-05-06 | 35.51% | -33.08% | -$0.11 | $6.98 |
| 2026-05-05 | 30.66% | -19.23% | -$0.10 | $6.94 |
| 2026-05-04 | 30.66% | -19.23% | -$0.10 | $6.64 |
| 2026-05-03 | 30.66% | -19.23% | -$0.10 | $6.33 |
| 2026-04-30 | 30.66% | -19.23% | -$0.10 | $6.39 |
| 2026-04-29 | 30.66% | -19.23% | -$0.10 | $6.27 |
| 2026-04-28 | 30.66% | -19.23% | -$0.10 | $6.30 |
| 2026-04-27 | 30.66% | -19.23% | -$0.10 | $6.46 |
| 2026-04-26 | 30.66% | -19.23% | -$0.10 | $6.40 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Taysha Gene Therapies Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Taysha Gene Therapies Inc (TSHA) has a next-year EPS growth estimate of 32.60%, based on analyst consensus.
When was the latest EPS estimate revision for TSHA?▾
The most recent revision occurred on 2026-05-10, when analysts adjusted the next-year EPS growth estimate from 33.95% to 32.60%.
What sector and industry does Taysha Gene Therapies Inc belong to?▾
Taysha Gene Therapies Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TSHA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Taysha Gene Therapies Inc (TSHA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports